Trial Profile
Safety and Efficacy of NOVOCART 3D in the Treatment of Articular Cartilage Defects Following Failure on Microfracture
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Mar 2022
Price :
$35
*
At a glance
- Drugs Autologous chondrocyte implantation (Primary)
- Indications Cartilage disorders
- Focus Therapeutic Use
- Sponsors Aesculap Biologics
- 01 Mar 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2028.
- 01 Mar 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2023.
- 12 Nov 2018 Status changed from not yet recruiting to recruiting.